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Abstract 
The purpose of the present study was to compare the prognostic value of personality 
psychopathology (PP) between patients with singular mood disorders, singular anxiety 
disorder, and comorbid mood and anxiety disorders. Previous studies showed that PP hampers 
treatment outcome more negatively in patients with mood disorders than in patients with 
anxiety disorders. However, differences in methodology, such as correcting for pretest 
severity or not, have yielded inconsistent findings between studies. A high negative impact of 
PP upon treatment outcome was predominantly expected for singular mood disorders and 
comorbid mood and anxiety disorders above and beyond the influence of pretest severity. An 
observational study was carried out and assessed 5755 patients with mood and/or anxiety 
disorders. Treatment outcome was operationalized as a continuous variable as well as a 
dichotomous variable. PP and symptoms of general psychopathology were assessed with the 
Dimensional Assessment of Personality Pathology Short Form and the Brief Symptom 
Inventory, respectively. Results showed a quite small negative effect of PP on outcome after 
controlling for pretest severity, gender, and age. The effects of PP were similar between the 
three diagnostic groups. Pretest severity was the best predictor of a negative outcome in all 
analyses. The potential confounding effects of pretest severity, and intensity and duration of 
treatment may explain the inconsistent findings between our study and previous studies. We 
advise further research to take these confounders into account when considering examination 
of the prognostic value of PP on treatment outcome. 
Keywords: personality psychopathology, mood disorders, anxiety disorders, treatment 
outcome, pretest severity, intensity 
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1. The differential prognostic value of personality psychopathology for treatment 
outcome of singular disorders, singular mood disorders, and comorbid mood and 
anxiety disorders 
1.1 Personality psychopathology         
A personality disorder is described as “an enduring pattern of inner experience and behaviour 
that deviates markedly from expectations of the individual’s culture, is pervasive and 
inflexible, has an onset in adolescence or early adulthood, is stable over time, and leads to 
distress or impairment” (DSM-5; American Psychiatric Association, 2013). The development 
and symptomatology of personality disorders is rather dimensional and continuous than 
categorical and dichotomous (Widiger, 1991), and therefore it is better to conceptualize 
personality disorders as personality psychopathology that represents maladaptive personality 
traits (Mulder, 2002). This form of psychopathology has often been dimensionally linked to 
axis I psychiatric disorders, such as mood and anxiety disorders (Eurelings-Bontekoe, 
Verheul, & Snellen, 2009; Siever, & Davis, 1991; Livesley, 1993; 1998; Joseph et al., 2001). 
In fact, Carlier et al. (2014) found that patients with comorbid mood and anxiety disorders 
displayed the most personality psychopathology (PP), followed by patients with singular 
mood disorders and singular anxiety disorders. They recommended to analyse the prognostic 
value of PP on treatment outcome for these three group of patients based on the finding that it 
could provide valuable information for the development of personalized treatments (Judd, 
Schettler, Coryell, Akiskal, & Fiedorowicz, 2013; Reich, 2007). According to clinical lore, 
complex clinical cases (i.e. patients with a primary anxiety or mood disorder as well as 
comorbid PP) have more often a disappointing treatment outcome than cases uncomplicated 
by comorbid PP. In view of the literature and this common opinion among therapists, the 
question whether the PP level has prognostic value for the treatment of mood and anxiety 
disorders has clinical importance.  
1.2 Primary disorder 
In the past, several studies have focused on analysing the prognostic value of PP for treatment 
outcome in different types of mood and anxiety disorders. Studies on anxiety disorders report 
little to no influence of PP on treatment outcome. For example, Dreessen and Arntz (1998) 
found little to no support for the prognostic value of PP for anxiety disorders in their review. 
They compared treatment response between patients with a comorbid personality disorders 
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and patients without a comorbid personality disorder. Treatment response was either defined 
as dichotomous variable that classified between responders and non-responders at end state 
based on whether there was a 50% reduction of symptoms or not, or as a continuous variable 
(i.e. posttest score corrected for pretest severity). The majority of the included studies found 
little to no influence of PP on treatment outcome (Chambless et al., 1995; Dreessen, Hoekstra, 
& Arntz, 1997; Hoffart, & Martinsen, 1993; Noyes et al., 1990). Another study by Kampman, 
Keijsers, Hoogduin, and Hendriks (2008) analysed treatment outcome for panic disorder, and 
did not find any influence of PP. On the contrary, these findings are rejected by other studies 
that did find a negative (and sometimes a positive) effect of PP on treatment outcome of 
anxiety disorders (Goddard, Wingrove, & Moran, 2015; Schat et al., 2015; Telch, Kamphuis, 
and Schmidt 2011; Sanatinia et al., 2016). The effect of PP was, however, small in some 
studies (Goddard et al., 2015; Telch et al., 2011). Treatment outcome was again either defined 
as a continuous variable, such as the change from pretest to posttest, or as a dichotomous 
variable, such as responders and non-responders. Goddard et al. (2015) examined both kind of 
outcomes, and found similar effects PP. Furthermore, the majority of the studies only 
analysed the influence of PP for one specific anxiety disorder, such as panic disorder (Noyes 
et al., 1990; Telch et al., 2011). Therefore, the generalizability of the prognostic value of PP 
to other anxiety disorders seems limited. 
Additionally, studies provide more convincing evidence for a greater negative impact of 
PP on treatment outcome for mood disorders than for anxiety disorders. For instance, van den 
Hout, Brouwers, and Oomen (2016) compared the prognostic value of PP for treatment 
outcome between three groups of patients with anxiety disorders and one group of patients 
with major depression. The depressed group showed less improvement in outcome measures, 
while the anxiety group was not affected by the presence PP (van den Hout et al., 2016). Their 
findings are in line with findings from other studies showing a negative impact of PP on 
treatment outcome of mood disorders (Shea et al., 1990; Goddard et al., 2015). Other studies, 
however, do not support this stance and report that PP has little to no impact on treatment 
outcome (Harte, & Hawkins, 2016; Mulder, 2002). Harte et al. (2016) even found more 
prognostic value of PP for generalized anxiety disorder and obsessive-compulsive disorder 
than for depression. Nonetheless, lack of peer-reviewed instruments, small data samples, and 
confounding variables (i.e. pretest severity) were addressed as some of the methodological 
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problems that account for the inconsistency between the studies (Mulder, 2002). A systematic 
meta-analysis conducted by Newton-Howes et al. (2014) implemented the pooling-technique 
and included studies with peer-reviewed instruments, as recommended by Mulder (2002). 
They subsequently found a negative effect of PP on treatment outcome for mood disorders. 
Noteworthy, results from this meta-analysis were limited in its power due to lack of control 
for pretest severity (Newton-Howes et al., 2014). Furthermore, treatment outcome was either 
defined as a continuous outcome variable, such as posttest score corrected for pretest severity 
or change scores (van den Hout et al., 2016; Goddard et al., 2015), or as a dichotomous 
variable, such as recovered versus unrecovered at end state functioning. A patient was 
considered recovered when it sustained treatment response until the end of treatment 
(Newton-Howes et al., 2014). 
Furthermore, in past research PP has also been associated with comorbid mood and 
anxiety disorders (Carlier et al., 2014). Studies have found lifetime comorbidity rates of 73% 
and 71%-85% between mood and anxiety disorders in community and clinical samples, 
respectively (Brown, Campbell, Lehman, Grisham, & Mancill, 2001; Lewinsohn, Zinbarg, 
Seeley, Lewinsohn, & Sack, 1997). Several studies showed that PP adversely effects 
treatment outcome when it involves patients with both mood and anxiety disorder (Tyrer, 
Seivewright, Ferguson, Murphy, & Johnson, 1993; Seivewright, Tyrer, & Johnson, 1998). For 
instance, cluster C personality disorders (i.e. avoidant, dependent, and paranoid) were found 
to predict worse outcomes in patients with unipolar depression and panic disorder and/or 
agoraphobia (Hoffart, & Martinsen, 1993). In view of the literature, it seems of clinical 
interest to investigate the differential prognostic value of PP in a group of patients with 
singular mood and anxiety disorders as well as comorbid mood and anxiety disorders. 
1.3 PP, outcome measurements, and data-analysis      
Whether a prognostic value is found may depend on how outcome is operationalized and 
measured, and what kind of data-analysis is conducted. These choices influence the findings 
of studies into the prognostic value of PP. In addition, findings may vary by the kind of PP 
and the kind of primary disorder. Thus, it is clinically relevant to search for differences 
between them. Furthermore, findings can also be sensitive to unmeasured confounders. For 
instance, Mulder (2002) recommended to control for the confounding effects of pretest 
severity when examining the impact of PP on treatment outcome of axis I disorders. Pretest 
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severity could have influenced findings from previous studies, as it is often demonstrated that 
pretest severity has a consistent and strong influence on posttest outcome of mood and anxiety 
disorders (Mulder, 2002; Kampman et al., 2008). For instance, the negative effects of PP were 
modest relative to the effects of pretest severity in the study by Hoffart and Martinsen (1993). 
Only Goddard et al. (2015), Kampman et al. (2008), Telch et al. (2011), and many studies 
reviewed in Dreessen and Arntz (1998) controlled for the potential effect of this confounder.  
1.4 Research questions and hypotheses       
Despite many research conducted into the prognostic value of PP for treatment outcome in 
mood and anxiety disorders, conclusive findings have not yet been found. In light of the 
mixed findings, the purpose of the present study was to further investigate the differential 
prognostic value of PP for treatment outcome in singular and comorbid mood and anxiety 
disorders above and beyond the influence of pretest severity. This study examined the 
prognostic value of PP in three different groups of patients: those with singular anxiety 
disorders, those with singular mood disorders, and those with comorbid mood and anxiety 
disorder. To analyse the prognostic value of PP independently, this study controlled for 
pretest severity by analysing two types of treatment outcomes: pretest severity posttest score 
corrected for pretest severity and pre-to-posttest change scores. Gender and age was also 
controlled for during the analyses. Based on the literature, we expected a higher impact of PP 
on treatment outcome for mood disorders as compared to anxiety disorders. Consequently, the 
first hypothesis was that PP has a greater negative effect on treatment outcome for singular 
mood disorders than for singular anxiety disorders. The second hypothesis was that PP has a 
greater negative effect on treatment outcome for comorbid mood and anxiety disorders than 
for singular anxiety disorders. Finally, this present study explored and compared the effect of 
PP on treatment outcome between comorbid mood and anxiety disorders and singular mood 
disorders.  
2. Methods 
2.1 Patients 
The data used in this present study comprised of a sample of 5755 outpatients who received 
treatment at GGZ Rivierduinen or the psychiatric department of Leiden University Medical 
Centre between 2004 and 2013. Patients with other disorders, such as somatoform disorders 
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or personality disorders, were excluded from the study. The data for this study included 
patients with a singular anxiety disorder, a singular mood disorder, or comorbid mood and 
anxiety disorders. The age of the included patients ranged from 17 to 82 years old. 
2.2 Research design  
Data were derived from a prospective cohort study which was carried out to assess treatment 
outcome for patients with mood, anxiety, and somatoform disorders.  For the present analysis, 
we used data from assessments that took place on two occasions; at the start of treatment and 
after six to eight months of treatment.  
2.3 Setting and procedures 
The first assessment took place as part of the intake procedure during which the patients were 
interviewed by a clinician. Patients were further asked to complete several self-report 
questionnaires (i.e. pretest). A second appointment was made after the interview to establish 
the treatment plan. Accordingly, patients were assigned to pharmacotherapy, psychotherapy 
(predominantly cognitive behavioural therapy), or combination therapy. At fixed time 
intervals patients were reassessed to monitor their progress (de Beurs, 2011). The second 
assessment took place at an evaluation session during which the patients were asked to again 
complete self-report questionnaires (i.e. posttest).  
2.4 Measurement instruments 
The present study assessed the following constructs: personality psychopathology as 
measured with the Dimensional Assessment of Personality Pathology Short Form at pretest, 
and severity of psychopathology as measured repeatedly with the Brief Symptom Inventory at 
pretest and posttest. Furthermore, the Dutch version of the Mini International 
Neuropsychiatric Interview-Plus was used during the intake procedure to establish the 
diagnosis of mood and anxiety disorders (van Vliet, & de Beurs, 2007). Psychometric 
evaluations demonstrated very good inter-rater and test-retest reliability with kappa 
coefficients between 0.76 and 1.00 (Lecrubier et al., 1997). 
Personality psychopathology. The Dimensional Assessment of Personality Pathology 
Short Form (DAPP-SF) is a 136-item self-report questionnaire assessing maladaptive 
personality traits (de Beurs, Rinne, van Kampen, Verheul, & Andrea, 2009). The items are 
clustered into 18 subscales and four higher-order constructs. The subscales submissiveness, 
cognitive distortion, identity problems, affective lability, oppositionality, anxiousness, 
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suspiciousness, social avoidance, narcissism, insecure attachment, and self-harm underlie the 
first higher-order construct “Emotional Dysregulation” (ED). The subscales stimulus seeking, 
callousness, rejection, and conduct problems underlie the second higher-order construct 
“Dissocial Behaviour” (DB). The subscales intimacy problems and restricted expression 
underlie the third higher-order construct “Inhibitedness” (IH). Finally, the subscale 
compulsivity underlies the fourth higher-order construct “Compulsivity” (CO; de Beurs et al., 
2009). The items are rated on a five-point Likert scale. DAPP-SF scores indicate the presence 
of personality pathology. Psychometric evaluations performed in community samples and 
clinical samples (i.e. patients with both axis-I and axis-II disorders) demonstrated good 
internal consistency with Cronbach’s alphas between 0.76 and 0.91 (de Beurs et al., 2009). 
Another psychometric evaluation performed in a community sample demonstrated good 
convergent validity for the higher-order constructs and subscales with correlations between 
0.42 and 0.71 (van Kampen, De Beurs, & Andrea, 2008). For the present statistical analysis, a 
two-staged procedure was chosen: if significant results were found for the higher-order 
constructs, underlying subscales were analysed as well (Carlier et al., 2014). Mean scores 
were calculated for each higher-order construct and each subscale, and were used as 
independent variables for the present statistical analysis.  
Symptoms of general psychopathology. The BSI-53 is a 53-item questionnaire assessing 
symptoms of depression, anxiety, somatization, obsession-compulsion, interpersonal 
sensitivity, hostility, phobic anxiety, paranoid ideation, and psychoticism (Derogatis, & 
Melisaratos, 1983). The items are rated on a five-point Likert scale, ranging from “not-at-all” 
to “extremely”. A psychometric evaluation was performed in a large population of psychiatric 
patients and demonstrated good test-retest reliability and good internal consistency with 
Cronbach’s alphas between 0.71 and 0.84 (De Beurs, & Zitman, 2005). The BSI total score 
ranged from 0 to 4, and was used as a dependent variable for the present statistical analysis. 
2.5 Operationalisation of outcome  
Treatment outcome was operationalized as the posttest score corrected for pretest severity (i.e. 
residual change scores). In past research, treatment outcome has been operationalized as 
percentage improvement (i.e. 50% reduction of symptoms; Dreessen, & Arntz., 1998; Schat et 
al., 2015). However, several disadvantages such as diminished statistical power and loss of 
valuable information have been associated with this method, as this categorical method 
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classifies patients into “responders” and “non-responders” based on a cut-off of 50% (de 
Beurs et al., 2015; Schat et al., 2013). Conversely, residual change scores (continuous 
variable) have shown more statistical power than categorical variables (de Beurs et al., 2015). 
Furthermore, as residual change scores do not provide clinically meaningful information, an 
alternative method called Reliable Change Index proposed by Jacobson and Truax (1991) was 
applied as an adjunct to analysis with residual change scores. This method emphasizes the 
importance of interpreting the amount of change between pretest and posttest, therefore pre-
to-posttest change scores were computed instead of residual change scores for the Reliable 
Change analysis. The Reliable Change Index transforms change scores into clinically more 
informative terms: deteriorated, unchanged, or improved (Jacobson, & Truax, 1991). To 
classify the patients, a cut-off score of 0.35 was chosen for the BSI change score. Patients 
were classified as reliably improved when their change score on the BSI was > 0.35 (a change 
in the direction of improvement). Patients were classified as reliably deteriorated if the change 
score was < -0.035 (a change in the direction of deterioration).  Patients with change scores 
between -0.35 and 0.35 were classified as unchanged. 
2.5 Statistical analysis 
Statistical Package for the Social Science (SPSS version 23; de Vocht, 2013) was used for the 
statistical analyses, which included descriptive statistics and testing statistics. The hypotheses 
“whether PP has a greater negative effect on treatment outcome for mood disorders than for 
anxiety disorders”, and “whether PP has a greater negative effect on treatment outcome of 
comorbid mood and anxiety disorders than for singular anxiety disorders” were tested by 
analysing the results of multiple regression analysis and hierarchical regression analysis. 
These results were further used to explore and compare the effect of PP on treatment outcome 
between comorbid mood and anxiety disorders and singular mood disorders.  
The sequence of analysis of residual change scores was as follows: firstly, BSI pretest 
score, gender, and age were entered as independent variables together with the higher-order 
PP constructs scores in a multiple regression model with the BSI posttest score as the 
dependent variable. This analysis was performed for the group with singular mood disorders 
(depression group), the group with singular anxiety disorders (anxiety group), and the group 
with comorbid mood and anxiety disorders (comorbid group). Secondly, hierarchical 
regression analysis was conducted to analyse which higher-order construct was the best 
Differential effects of PP on treatment outcome 
 
12 
 
 
 
predictor of BSI posttest score. This second analysis was conducted by choosing the stepwise 
entry method. The results of the multiple regression analysis and hierarchical analysis were 
further used to explore and compare the effect of higher-order PP constructs on BSI posttest 
score between comorbid mood and anxiety disorders and mood disorders. Third, if DAPP 
higher-order PP constructs had significant effects, the prognostic value of the 18 underlying 
subscales of the constructs were analysed as well. Only multiple regression analysis was 
conducted for this analysis. Construct CO has only one subscale, therefore custom tables were 
inspected to see whether the mean score of the subscale was the same as the mean score of the 
higher-order construct. We chose to only analyse the higher-order construct in the case the 
mean scores were the same. Furthermore, raw data of all independent and dependent variables 
were measured at an interval level. For every analysis, a two-tailed test with a significance 
level p ≤ 0.05 was chosen. 
The following inspections were done to meet the assumptions of multiple linear 
regression: the Variance Inflation Factor of the variables was analysed to rule out 
multicollinearity. A Variance Inflation Factor between one and ten indicates that the 
assumption of linear independence is not violated. When a Variance Inflation Factor (VIF) 
exceeds ten, it is very likely that two or more predictor variables are highly correlated with 
each other (de Vocht, 2013). Variable deletion is then considered in order to prevent 
distortion of results (Pituch, & Stevens, 2016). Additionally, the presence of influential cases 
within the independent variables was calculated with Cook’s distance and leverage values. 
Cases with a Cook’s distance larger than 1 and/or leverage value larger than 0.5 have 
substantial influence on regression coefficients (de Vocht, 2013). Scatterplots were visually 
inspected to further analyse such cases. In addition, P-P plots and scatterplots were created to 
control if residuals were normally distributed, and if there was homogeneity of variance (i.e. 
homoscedasticity). Finally, bivariate correlations were conducted to analyse the relationship 
between BSI posttest score and each higher-order construct.  
The sequence of analysis of change scores according to the Reliable Change Index 
(RCI; Jacobson, & Truax, 1991) was as follows: first, Delta BSI score was computed by 
subtracting the pretest score from the posttest score on each measure. Second, Reliable 
Change variable was computed based on the Delta BSI score. Reliable Change is a categorical 
variable with three levels: improved (Delta BSI score > 0.35), unreliable change (Delta BSI 
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score ≤ 0.35 and ≥ -0.35) and deteriorated (Delta BSI score < -0.35). Reliable Change was 
recoded into two dummy variables: Reliable Improvement (1 = improved, 0 = unchanged), 
and Reliable Deterioration (1= deteriorated, 0 = unchanged). Binary logistic analysis was 
conducted to analyse whether the four higher-order PP constructs predict categorical outcome 
for all three diagnostic groups. Again, two-tailed tests with a significance level p ≤ 0.05 were 
chosen. 
3. Results 
3.1 Sample characteristics  
The data sample of N = 5755 included patients with singular anxiety disorders, singular mood 
disorders, and comorbid mood and anxiety disorders. The mean age was M = 3893, SD = 
12.5, and most of the patients were female (64.2%). With regard to clinical data, most patients 
were diagnosed with comorbid mood and anxiety disorders (n = 2061; 26.4%) patients). A 
further N = 2014 (25.8%) were diagnosed with a singular anxiety disorder. Finally, N = 1680 
(21.5%) were diagnosed with a singular mood disorder. Demographic data of the sample are 
presented in Table 1. Frequencies of specific mood and anxiety disorders are presented in 
Appendix 1. Major depressive disorder (recurrent, moderate), posttraumatic stress disorder, 
and generalized anxiety disorders were the most common disorders in the data sample: N = 
1232 (21,4%), N = 898 (15,6%), and N = 898 (15,6%), respectively. 
Table 1 
Baseline characteristics in 5755 outpatients diagnosed with mood or anxiety disorders,  
who received treatment at GGZ Rivierduinen or the LUMC between 2004 and 2013 
Demographic data     M(SD)     
Age     38.9(12.5)   
        N   % 
Gender             
Male       2138   37,2% 
Female       3617   62,8% 
 
3.2 Preliminary analyses 
The total number of missing values on the DAPP self-report questionnaire scores was only 
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four. The CO construct had three missing values, and the DB construct had one missing value. 
These four cases were excluded from the regression analysis. As the number of missing 
values was low, no further analysis of missing values was conducted. Predictor variables had 
a Variance Inflation Factor between one and ten. This indicates that the variables were 
sufficiently uncorrelated. The P-P plot indicated that errors were normally distributed between 
independent and dependent variables. Some points were not completely on the line, but close. 
The scatterplot of standardized residuals indicated that the assumption of homogeneity of 
variance was met. Cook’s distance and leverage values demonstrated that there were no 
individual cases with large influence on the regression coefficients. The highest Cook’s 
distance values were 0.016, 0.018, and 0.14 for the depression group, anxiety group, and 
comorbid group, respectively. The highest leverage values were 0.017, 0.014, 0.022 for the 
three groups, respectively. With regard to bivariate correlations, the relationship between BSI 
pretest score and BSI posttest score was significant and of medium size, r = 0.540, p < 0.05. 
The relationship between gender and BSI posttest score was not significant, r = 0.003, p = 
0.829. Finally, the relationship between age and BSI posttest score was significant and weak, 
r = -0.030, p < 0.05. After controlling for BSI pretest score, gender, and age, only BSI pretest 
score remained significant in multiple regression models. BSI pretest score was also the best 
predictor of BSI posttest score in hierarchical regression models for all three groups. It had B-
values of 0.491, 0.453 and 0.351 for comorbid group, depression group, and anxiety group, 
respectively (Table 2). Within the depression group, 25% of the variance was explained by 
BSI pretest score. Finally, 26% and 20% of the variance was explained by BSI pretest score 
within the anxiety group and comorbid group, respectively. Gender and age were not 
significant predictors in the hierarchical models for anxiety and comorbid group. Only gender 
was significantly associated with outcome in the depression group: woman had better 
outcomes than men. 
3.3 Does PP have a greater negative effect on treatment outcome for singular mood 
disorders than for singular anxiety disorders? 
Next, the four higher-order PP constructs (ED, DB, IH, and CO) were analysed in addition to 
BSI pretest score, gender, and age. Table 2 displays the effect of the constructs on the BSI 
posttest score for the depression group, the anxiety group and the comorbid group. 
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The findings for the singular depression group were as follows: higher ED and IH 
scores, and lower CO scores independently predicted higher BSI posttest scores after 
controlling for BSI pretest score, gender, and age. DB was not a significant predictor of BSI 
posttest score. The model was significant and had a medium R-square value of R
2
 = 0,257, p 
< 0.05. After applying the hierarchical method with stepwise entry, higher ED appeared to 
predict BSI posttest score, followed by higher IH and lower CO. DB remained a 
nonsignificant predictor of BSI posttest score. The addition of the significant higher-order PP 
constructs was associated with small, significant improvements in R
2
 = 0,253, p < 0.05; ED = 
0.007; IH = 0.002, CO = 0.002.  
Only Higher ED scores independently predicted higher BSI posttest scores within the 
anxiety group after controlling for BSI pretest score, gender, and age. Higher DB and IH 
scores were significant in the multiple regression analysis, but did not remain significant in 
the hierarchical analysis. CO was not a significant predictor of BSI posttest score in both 
analyses. The model of the multiple regression analysis was significant and had a medium R-
square value of R
2
 = 0,287, p < 0.05. Similar to the depression group, the significant higher-
order ED construct only had small significant changes in the hierarchical model, R
2
 = 0,284, p 
< 0.05; ED = 0,027. 
In summary, the higher-order PP constructs did not have a greater negative effect on 
treatment outcome for mood disorders than for anxiety disorders. The constructs were 
significant in the multiple regression model, but explained very little additional variance in 
the hierarchical model for both groups. ED was the best predictor of treatment outcome for 
both groups, and explained more variance within the anxiety group than within the depression 
group. The negative effects of the remaining higher-order PP constructs on treatment outcome 
for the depression group were similar to the effects on treatment outcome for the anxiety 
group. CO had a significant positive effect on treatment outcome for depression group. 
3.4 Does PP have a greater negative effect on treatment outcome for comorbid mood 
and anxiety disorders than for singular anxiety disorders? 
Similar to the results for the depression group, higher ED and higher IH scores, and lower CO 
scores independently predicted higher BSI posttest scores after controlling for BSI pretest 
score, gender, and age. DB was not a significant predictor of BSI posttest score. The model 
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was significant and had a medium R-square value of R
2
 = 0,230, p < 0.05. After applying the 
hierarchical method with stepwise entry, higher IH appeared to predict BSI posttest score the 
most, followed by higher ED and lower CO. Similar to the results of the singular groups, the 
significant predictors only had small, significant changes in R
2
 = 0,230, p < 0.05; IH = 0.006; 
ED = 0.001; CO = 0.002. Again, DB was not a significant predictor in the hierarchical model.  
In summary, the higher-order PP constructs did not have a greater negative effect on 
treatment outcome for the comorbid group than for the anxiety group. ED also explained 
more variance within the anxiety group than within the comorbid group. The negative effects 
of the remaining higher-order PP constructs on treatment outcome for the comorbid group 
were similar to the effects on treatment outcome for the anxiety group. CO had a significant 
positive effect on treatment outcome for comorbid group. 
3.5 Explorative analysis of the difference in prognostic value of PP between comorbid 
mood and anxiety disorders and singular mood disorders 
Table 2 shows that the effect of the higher-order PP constructs on BSI posttest score was 
relatively similar between the comorbid group and the depression group. The biggest 
difference in the effect of PP was a difference of 0.042 for IH; B-values of IH were 0.058 and 
0.100 for the depression and the comorbid group, respectively. The amount of explained 
variance was similar and small: R
2
 = 0.257 and R
2
 = 0.230 for the depression group and 
comorbid group, respectively. ED had a slightly greater negative effect on BSI posttest score 
for the depression group than for the comorbid group. IH and CO had a slightly greater 
negative effect on BSI posttest score for the comorbid group than for the depression group. 
Table 2 
Multiple regression analysis examining the effect of higher-order PP constructs on BSI 
posttest score after a maximum of six months of treatment 
  
B (SE) Beta T P 95% CI 
Selection variable: depression group 
    F(7, 1671), 82,48, p < 0.05; Adj. R
2
 = 0.254 
   ED 
 
(0,091(0,031)  0,087  2,904 0,004** 0,030-0,153 
IH 
 
(0,058(0,023)  0,056  2,477 0,013** 0,012-0,104 
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CO 
 
-0,033(0,016) -0,046 -2,092 0,037** -0,064 to  
-0,002 
DB 
 
(0,049(0,030)  0,042  1,622 0,105 -0,010 to 
0,108 
BSI pretest score (0,453(0,028)  0,431  16,064 0,000** 0,397-0,508 
Gender  -0,035(0,031) -0,026  -1,125 0,261 -0,096 to 
0,026 
Age  (0,001(0,001)  0,024  1,070 0,285 -0,001 to 
0,003 
Selection variable: anxiety group 
   F(7, 2004) = 115,49, p < 0.001; Adj. R
2
 = 0.287 
   ED 
 
 0,178(0,025) 0,200 7,018 0,000** 0,128-0,228 
DB 
 
 0,051(0,025)  0,045  2,042 0,041** 0,002-0,101 
IH 
 
 0,038(0,018)  0,042  2,082 0,037** 0,002-0,075 
CO 
 
-0,019(0,012) -0,031 -1,541 0,124 -0,042-0,005 
BSI pretest score  0,351(0,028)  0,363 14,380 0,000** 0,303-0,398 
Gender   0,010(0,024)  0,009  0,436 0,663 -0,036 to 
0,057 
Age   0,002(0,001)  0,038  1,941 0,052 0,000-0,003 
Selection variable: comorbid anxiety and depression group 
  F(7, 2052) = 87,61, p < 0.05; Adj. R
2
 = 0.230 
   ED 
 
 0,071(0,035)  0,055  2,028 0,043**  0,002-0,140 
IH 
 
 0,100(0,027)  0,079  3,756 0,000**  0,048-0,152 
CO 
 
-0,038(0,017) -0,045 -2,210 0,027** -0,072 to  
-0,004 
DB 
 
 0,024(0,034)  0,016  0,695 0,487 -0,043 to  
0.090 
BSI pretest score  0,491(0,029)  0,421 16,801 0,000**  0,433-0,548 
Gender   0,000(0,036)  0,001  0,003 0,998 -0,071 to  
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Note: ED denotes Emotional Dysregulation; IH denotes Inhibitedness; CO denotes 
Compulsivity; DB denotes Dissocial behaviour; CI denotes confidence interval 
* adjusted for gender and age 
** p < 0.05 
3.6 Unique subscales of the higher-order constructs 
Next, the unique subscales of the significant higher-order PP constructs were analysed in 
addition to pretest BSI score, gender, and age for all three groups. The subscales of ED were 
analysed within all three groups. The subscales of IH were only analysed within the 
depression and comorbid group. This higher-order construct was not a significant predictor of 
treatment outcome within the anxiety group. The same holds for DB whose subscales were 
only analysed within the anxiety group. Subscale CO was not analysed, as it had the same 
mean value as its higher-order construct CO; M = 2.89, M = 2.87, and M = 3.01 for the 
anxiety group, depression group, and comorbid group, respectively. Predictor variables had a 
Variance Inflation Factor between one and ten. This indicates that the variables were 
sufficiently uncorrelated. Cook’s distance and leverage values demonstrated that there are no 
individual cases with high influence on the regression coefficients. The highest Cook’s 
distances were 0.028, 0.019, and 0.009 for the depression group, anxiety group, and comorbid 
group, respectively. The highest leverage values were 0.040, 0.44, and 0.44 for the three 
groups, respectively.  
The findings for the depression group were as follows: higher cognitive distortion, 
affective lability, oppositionality, suspiciousness, and lower submissiveness scores (all 
subscales of ED), and higher intimacy problems (a subscale of IH) scores independently 
predicted a higher BSI posttest score after controlling for BSI pretest score, gender, and age. 
These analyses resulted in significant and medium R-square values of R
2
 = 0,271 and the R
2 
= 
0.248, p < 0.05 for the ED model and IH model, respectively. 
0,071 
Age   0,000(0,001)  0,003  0,171 0,864 -0,003 to 
0,003 
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Similarly, higher Cognitive Distortion,  Oppositionality, Suspiciousness, Self-harm, and 
Lower submissiveness scores (all subscales of ED) independently predicted higher BSI 
posttest score for the anxiety group after controlling for BSI pretest score, gender, and age. 
The ED model had a significant and medium R-square value of R
2
 = 0.299, p < 0.05. 
The significant subscales of ED and IH for the depression group with the addition of 
higher Self-harm and lower Narcissism also independently predicted independently predicted 
higher BSI posttest score for the comorbid group after controlling for BSI pretest score, 
gender, and age (except for oppositionality and cognitive distortion). Likewise, significant 
and medium R-square values of R
2
 = 0.238 and R
2
 = 0.231, p < 0.05 were found for the ED 
model and the IH model, respectively.  
Based on the results regarding the subscales three figures were created, as shown below, 
where the figures represent the three groups. The size of the circle corresponds to the amount 
of influence that the respective variable exerts. All 18 subscales instead of only the significant 
subscales were included to demonstrate the proportionality between significant subscales and 
nonsignificant subscales. As such, the smallest circles were not significant and had very small 
B-values ranging from 0.001 to 0.036. The t values, p values and confidence intervals in 
addition to the prognostic values of the subscales for all three groups are presented in 
Appendix 2.  
 
 
 
 
 
 
Legenda   
1. Submissiveness 
2. Cognitive distortion 
3. Identity problems 
4. Affective lability 
5. Oppositionality 
6. Anxiousness  
7. Suspiciousness  
8. Social avoidance 
9. Narcissism 
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18. Compulsivity 
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Figur
e 1. 
Prognostic profile based on the B-value of the 18 unique subscales of the four higher-order PP 
constructs for depression, anxiety, and comorbid group. * p < 0.5 
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3.7 Reliable Change Index according to Jacobson and Truax (1991) 
The Reliable Change Index showed that 3205(55.7%) patients were reliably improved with a 
Delta BSI score greater than 0.35. A further N = 2011(34.9%) patients had no reliable change. 
Finally, 539(9.4%) patients were reliably deteriorated with a Delta BSI score less than -0.35. 
Next, the association between higher-order PP constructs and Reliable Improvement 
was compared between the three groups of patients. The findings for the depression group 
were as follows: a test of the full model for Reliable Improvement was statistically 
significant, 2(6, N = 1680) = 43.34, p < 0.001. The model had an overall success rate of 
64.9%. Only ED and CO had significant partial effects. Moreover, the model fitted the data as 
Hosmer and Lemeshow was not significant, p = 0.089. The positive value for both higher-
order PP constructs indicated that patients who had high ED and CO scores were more likely 
to be in the improved group than in the unchanged group.  
The findings for the anxiety group were as follows: a test of the full model for Reliable 
Improvement was statistically significant, 2(6, N = 2014) = 119.33, p < 0.001. The model 
had an overall success rate of 61.5%. Only ED and CO had significant partial effects. Hosmer 
and Lemeshow was not significant, p = 0.617. Similar to depressed patients, patients with 
anxiety disorders and high ED and CO scores were more likely to be in the improved group 
than in the unchanged group. 
The findings for the comorbid anxiety and depression group were as follows: a test of 
the full model for Reliable Improvement was statistically significant, 2(6, N = 2061) = 23,71,  
p < 0.001. The model had an overall success rate of 66.9%. Only ED had significant partial 
effects. Hosmer and Lemeshow was not significant, p = 0.23. The positive value for ED 
indicates that patients who have a comorbid mood and anxiety disorder as well as high ED 
scores are more likely to be in the improved group than in the unchanged group. Table 3 on 
the next page displays the logistic coefficients, Wald test, and odds ratio of each of the 
predictors for the three groups. 
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Table 3 
Binary logistic regression predicting Reliable Improvement from higher-order PP constructs 
within depression group, anxiety group, and comorbid group  
Predictor     B(SE) Wald (2) P Odds ratio 95% CI 
for odds 
ratio 
Selection variable: depression group 
ED  0.439(0.106)  17.245  0.000** 1.551 1.26-1.90 
DB   -0.165(0.119)  1.930  0.165 0.848 0.67-1.07 
IH   -0.005(0.091)  0.003  0.955 0.995 0.83-1.19 
CO    0.136(0.062)  4.891  0.027** 1.146 1.02-1.29 
Gender      0.211(0.120)  3.073  0.080 1.234 0.98-1.56 
Age     -0.009(0.004)  3.881  0.049 0.991 0.98-1.00 
Selection variable: anxiety group 
ED  0.784(0.095)   61.439  0.000**  2.114 1.75-2.55 
DB -0.038(0.113)  0.115  0.734  0.962 0.77-1.20 
IH  0.003(0.083)  0.001  0.976  1.003 0.85-1.18 
CO  0.126(0.055)  5.339  0.021**  1.135 1.02-0.26 
Gender  0.064(0.107)  0.357  0.550  1.066 0.86-1.32 
Age -0.005(0.004)  1.522  0.217  0.995 0.99-1.00 
Selection variable: comorbid anxiety and depression group 
ED  0.310(0.095)   10.59  0.001**  0.73 0.61-0.88 
DB  0.022(0.107)  0.04  0.838  1.02 0.83-1.26 
IH  0.088(0.083)  1.12  0.289  1.09 0.93-1.29 
CO -0.103(0.055)  3.49  0.062  0.90 0.81-1.01 
Gender -0.013(0.114)  0.01  0.907  0.99 0.79-1.23 
Age   0.005(0.004)  1.29  0.256  1.01 1-1.01 
Note: ED denotes Emotional Dysregulation; IH denotes Inhibitedness; CO denotes 
Compulsivity; DB denotes Dissocial behaviour; CI denotes confidence interval 
* adjusted for gender and age 
** p < 0.05 
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Next, the association between higher-order PP constructs and Reliable Deterioration 
was compared between the three groups of patients. The full model for Reliably Deterioration 
was statistically not significant, 2(6, N = 2014) = 8.642, p = 0.195 and 2(6, N = 2061) = 
5.93, p = 0.431 for the depression group and comorbid group, respectively. The four higher-
order constructs were not further examined within these two groups. The full model for 
Reliable Deterioration was statistically significant for the anxiety group, 2(6, N = 2014) = 
29.75, p < 0.001. The model had an overall success rate of 83.8%. Only ED had significant 
partial effects. Moreover, the model fits the data as Hosmer and Lemeshow was not 
significant, p = 0.74. The positive value for ED indicated that patients who had high ED 
scores were more likely to be in the deteriorated group than in the unchanged group. The 
logistic regression coefficients, Wald test, and odds ratio of each of the predictors for the 
anxiety group are presented in table 4. 
Table 4 
Binary logistic regression predicting Reliable Deterioration from higher-order PP constructs 
within the anxiety group 
Predictor   
 
  B(SE) Wald (2) P Odds ratio 95% CI 
for odds 
ratio 
Emotional dysregulation 0.616(0.165)  13.996  0.000**  1.851 1.34-2.56 
Dissocial behaviour   0.303(0.198)  2.330  0.127  1.354 0.92-2.00 
Inhibitedness   -0.008(0.149)  0.003  0.959  0.992 0.74-1.33 
Compulsivity   -0.027(0.100)  0.074  0.786  0.973 0.80-1.18 
Gender     0.091(0.190)  0.230  0.631  1.095 0.75-1.59 
Age     0.004(0.007)  0.282  0.595  1.004 0.99-1.02 
Note: DAPP-SF denotes Dimensional Assessment of Personality Psychopathology-Short 
Form; CI denotes confidence interval 
* adjusted for gender and age 
** p < 0.05 
3.8 Summary of results         
BSI pretest score was a significant predictor of BSI posttest score within all three diagnostic 
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groups. The prognostic value of BSI pretest score was substantially higher than the prognostic 
values of the four DAPP higher-order constructs and the 18 unique subscales. Gender was 
also a significant predictor of BSI posttest score within the depression group, but showed little 
prognostic value. The amount of explained variance by these four constructs was uniform 
across the groups. The four higher-order constructs ED, DB, IH, and CO did not have a 
greater negative effect on BSI posttest score for mood disorders and comorbid mood and 
anxiety disorders than for singular anxiety disorders. Emotional dysregulation had a greater 
negative effect on BSI posttest score for the anxiety group than for the depression and 
comorbid group. The remainder of the constructs had relatively similar B-values between the 
three groups. For example, Dissocial Behaviour was not significant in all three groups. 
Explorative analysis of the effect on BSI posttest score between the comorbid group and the 
depression group showed that the negative effect of higher-order constructs on BSI posttest 
score were relatively similar and did not have much comparative value.  
The results with regard to the 18 unique subscales of the DAPP higher-order constructs 
yielded a personality profile for each subgroup. Lower submissiveness scores significantly 
predicted higher BSI posttest scores within all three groups. Lower narcissism and rejection 
scores also significantly predicted higher BSI posttest score within the comorbid group. The 
remainder of significant subscales had negative B-values. 
The results of the binary analysis according to the  RCI method showed that higher ED 
scores predict improvement within all three groups. Higher ED scores also predicted 
deterioration within the anxiety group. Finally, higher CO scores predicted improvement 
within the depression group. IH and DB were not significant predictors of improvement and 
deterioration.        
4. Discussion 
This present study aimed to investigate whether the impact of PP on treatment outcome 
differs according to type of primary disorder. We compared the effects of PP on treatment 
outcome between three diagnostic groups: patients with mood disorders, patients with anxiety 
disorders, and patients with both mood and anxiety disorders. It was expected that PP would 
have a greater negative impact on outcome in patients with singular mood disorders or 
comorbid mood and anxiety disorders than for singular anxiety disorders. We also compared 
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the effect of PP on treatment outcome between singular mood disorders and comorbid mood 
and anxiety disorders. As expected, PP predicted treatment outcome above and beyond the 
influence of pretest severity, gender, and age. It was justified to control for pretest severity, as 
this demonstrated to be a consistent and important predictor of treatment outcome for all three 
groups. The prognostic value of pretest severity was even greater than the prognostic value of 
PP (i.e. the four higher-order constructs and the 18 subscales). Our finding that 20% to 26% 
of the variance in outcome was explained by pretest severity replicates findings of a study by 
Kampman et al. (2008) who found explained variance rates between 20% to 51%. It is, 
however, a common finding that pretest severity affects posttest treatment outcome and 
several studies emphasize the importance of taking this confounder into account (Mulder, 
2002; Ramnerö, & Ost, 2004). Gender was also a predictor of treatment outcome, but solely 
for the depression group and showed negligible prognostic value. 
The findings of this present study do not support the hypotheses that PP has a stronger 
negative impact on outcome in patients with singular mood disorders and comorbid mood and 
anxiety than in patients with singular anxiety disorders. Although personality 
psychopathology was associated with worse outcomes in all three diagnostic groups, the 
effect of PP on outcome was quite small. It is surprising that the negative effects of the four 
higher-order PP constructs and 18 subscales on treatment outcome were largely similar 
between the three groups. Another unexpected finding was that Emotional Dysregulation 
predicted worse outcome and more so for patients with anxiety disorders than for patients 
from the other two groups. Furthermore, we found that the higher-order PP constructs had 
similar negative effects on treatment outcome in patients with singular mood disorders and 
comorbid mood and anxiety disorders. In contrast to our hypotheses, we found that one 
higher-order construct (Compulsivity) was associated with better outcomes in patients with a 
mood disorder or a comorbid mood and anxiety disorder. Compulsivity had no prognostic 
value for singular anxiety disorders. At subscale level, Submissiveness was found to predict 
better outcomes in all three groups. Narcissism was found to predict better outcomes in 
patients with comorbid mood and anxiety disorders. The positive findings regarding anxiety 
disorders confirm an earlier finding that patients with mild to moderate personality problems 
and hypochondria show improvement in CBT (Sanatinia et al., 2016).  
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Personality psychopathology was further examined in relation to the clinical end state of 
a patients (i.e. improved, unchanged or deteriorated). The effect of PP on the direction of 
change within the patients was very similar between the diagnostic groups. Emotional 
Dysregulation predicted improvement on the binary outcome variable in all three groups, 
which is surprising given the previous finding that Emotional Dysregulation predicts a 
negative outcome on the continuous variable. Several reasons may explain this inconsistency. 
Firstly, we transformed our initial continuous outcome (i.e. residual change scores) into a 
dichotomous variable (end state based on change scores) to determine the direction of change, 
hence used two different treatment outcomes. It is possible that the effect changed according 
to the kind of treatment outcome. Secondly, the negative effects of the higher-order PP 
constructs on the continuous outcome were quite small. Due to its small magnitude, this effect 
may have easily changed from a negative effect into a positive effect on the binary outcome 
variable. Furthermore, Compulsivity predicted improvement, but solely for the depression 
group. This finding is in line with the results of the analyses on the continuous outcome, as 
this higher-order construct was found to predict a better outcome within the depression group. 
Apparently, Compulsivity has a positive, albeit small, effect on the outcome of treatment for 
depression, but not when (comorbid) anxiety is present. Perhaps that this type of PP plays a 
role in facilitating treatment for patients with a mood disorder. Depressed patients typically 
feel worthless and don’t have much confidence, and some compulsivity may help them abide 
more closely to therapeutic instructions and assignments (Faber, & O’Guinn, 1989).  
4.1 Strengths and weaknesses 
This present study has high external validity due to the broad inclusion criteria, dimensional 
measuring of PP, and large sample size. The observational nature of the study, the fact that we 
controlled for pretest severity, and the fact that we examined two different treatment 
outcomes also strengthen our findings. By collecting data in everyday clinical practice, a large 
representative sample from clinical institutions was created. Hereby, the generalizability of 
the findings to day-to-day patients is high (Mulder, 2002). In addition, the choice to measure 
PP dimensionally further increased the strength of our study (Newton-Howes et al., 2014). 
Previous studies consistently criticized categorical definitions of PP (i.e. personality disorder), 
because there is still no consensus on how to classify patients with personality problems the 
best (Newton-Howes et al., 2014; Bernstein, Iscan, & Maser, 2007). The DAPP-SF used in 
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this present study measures “personality traits over a continuum of adaptive to maladaptive, 
whereas personality disorders are maladaptive by definition” (Carlier et al., 2014). 
Nevertheless, one must be aware that simply having personality traits does not equal having a 
personality disorder (Widiger, & Costa, 2012). The new DSM-5 takes this notion into account 
and developed an alternative model that proposes that the combination of diagnosed 
characteristics of a personality disorder and maladaptive personality traits lead to a diagnosis 
of personality disorder (Berghuis Kamphuis, & Verheul, 2014). 
The findings should also be considered in light of several of limitations. Firstly, 
systematic information about the intensity and duration of the treatment was lacking. The fact 
that we only found little prognostic value of PP can be due to differences in treatment 
provided to patients with and without PP. Possibly, patients with (severe) maladaptive 
personality traits were treated more intensively and longer than patients without maladaptive 
personality traits. Ultimately, well adapted treatment may have mitigated the effect of PP on 
treatment outcome. A study that supports this notion is a study by Dreessen, Hoekstra, and 
Arntz (1997) who found no differences between PD and non-PD patients after additional 
treatment for the PD patients. Secondly, we do not have information about type of treatment, 
therefore it was not possible to control for the potential confounding effects of this factor. 
Shea et al. (1998) demonstrated that type of treatment has differential effects on outcome 
between depressed patients with PD and without PD. For example, patients with PD benefited 
more from cognitive behavioural therapy, whereas patients without PD benefited more from 
interpersonal therapy or medical therapy (Shea et al., 1998). Thirdly, we used self-report 
questionnaires to measure PP and the level of depression and anxiety. This type of instrument 
is sensitive to social desirability and requires a certain amount of self-awareness in patients 
for them to report accurately about their symptoms and behaviours (Edwards, 1957). 
However, both BSI-53 and DAPP-SF demonstrated good psychometric properties (de Beurs, 
& Zitman, 2005; de Beurs et al., 2009). Moreover, the DAPP-SF has proven itself to be a 
good measure of maladaptive personality profiles, and adequately distinguishes between 
samples with and without personality disorders (de Beurs, Rinne, van Kampen, Verheul, & 
Andrea, 2010). Fourth, the extent to which this present study can be compared to previous 
studies is limited, as there is no consistent methodology between the studies. This is not 
necessarily a limitation of the present study, but rather a general weakness of research 
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conducted into the prognostic value of PP. As noted in the introduction, whether a prognostic 
value of PP is found may depend on the operationalization of PP, the operationalization and 
measurement of outcome, type of primary disorder, and kind of data-analysis. Previous 
studies used various operationalisations of treatment outcomes and various approaches to 
measure PP. In addition, some studies controlled for pretest severity, whereas other studies 
did not.  
4.2 Depression and anxiety 
To an extent our findings replicate findings of previous studies that PP has a negative impact 
upon treatment outcome in patients with mood disorders (Shea et al., 1998; Goddard et al., 
2015; van den Hout et al., 2016). The effect of PP on treatment outcome was, however, quite 
small as compared to what a thoroughly conducted meta-analysis by Newton-Howes et al. 
(2014) had found. They demonstrated convincing evidence that depressed patients with a 
comorbid personality disorder were twice as likely to be unresponsive to treatment as 
depressed patients without a comorbid personality disorder (Newton-Howes et al., 2014). This 
inconsistency is also found when comparing the influence of PP on treatment outcome for 
anxiety disorders between our study and previous studies. Remarkably, our finding that PP 
also had a negative prognostic value upon treatment outcome of anxiety disorders contradicts 
earlier conclusions that PP has no impact for anxiety disorders (Dreessen, & Arntz, 1998; 
Kampman et al., 2008), and replicates findings of other studies with patients with anxiety 
disorders (Telch et al., 2011; Schat et al., 2014; Goddard et al., 2015). 
Based on the earlier notion that the prognostic value of PP differs according to type of 
methodology, we may assume that two factors have caused this inconsistency between our 
study and previous studies. Firstly, many studies did not take the importance of pretest 
severity into account, and found high effect of PP on treatment outcome for mood disorders 
(Newton-Howes et al., 2014; Shea et al., 1998), and little to no effect of PP on treatment 
outcome for anxiety disorders (Black, Wesner, Gabel, Bowers, & Monahan, 1994; Dreessen, 
Hoekstra, & Arntz, 1997). Since pretest severity proved to be a strong and consistent 
influence on treatment outcome in the present study and previous studies, it is plausible that 
PP has lesser prognostic value for mood disorders when pretest severity is controlled for. This 
may explain why the effect PP was small in our study compared to the high effects in studies 
that did not control for pretest severity (Newton-Howes et al., 2014). Likewise, previous 
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studies that controlled for pretest severity also found a small effect of PP on treatment 
outcome for both singular mood disorders. For instance, Goddard et al. (2015) found very 
small changes in explained variance within both the depression group and anxiety group (R-
squared change of 0.005) after adding PP and pretest severity as independent variables. 
Similarly, van den Hout et al. (2016) found a relatively weak influence of PP (Eta square of 
0.12 for group x time interaction on depression score) on treatment outcome for mood 
disorders.  
At the same time, the influence of pretest severity could have obscured possible 
negative effects of PP on treatment outcome for anxiety disorders in previous studies (Black 
et al., 1994). For instance, Black et al. (1994) that did not control for pretest severity and 
found no effect of PP on treatment outcome for panic disorders. Another study by Schat et al. 
(2015) examined the effect of PP on treatment outcome with the DAPP-SF without 
controlling for pretest severity, and found that only two subscales (i.e. affective lability and 
behaviour problems) had a small effect on treatment outcome. The present study, on the other 
hand, found prognostic value for several higher-order constructs and subscales of the DAPP-
SF. Nonetheless, controlling for pretest severity still did not lead to higher effects of PP on 
treatment outcome. As mentioned earlier, pretest severity was the best predictor of outcome in 
our study. Similarly, Hoffart and Martinsen found that pretest severity had a greater negative 
effect on treatment outcome (explained variance rates between 12.4% and 24%) than the 
cluster C personality disorders (rates between 4.8% and 14.9%) in patients with unipolar 
depression and panic disorder and/or agoraphobia. Other studies that controlled for pretest 
severity also found limited of PP on treatment outcome for anxiety disorders (Dreessen et al., 
1997; Chambless et al., 1995; Goddard et al., 2015; Telch et al., 2011). A study that examined 
panic disorders even found no effect of PP on treatment outcome after controlling for pretest 
severity (Kampman et al., 2008).  
Secondly, we highlight the intensity and duration of treatment as an important factor 
that may have altered the outcome in our study and previous studies. As mentioned earlier, we 
did not consider the potential confounding effects of this factor, and therefore we did not have 
an entirely pure measure of the effect of PP on treatment outcome. Some studies that also did 
not consider the intensity of treatment found great negative effects of PP on treatment 
outcome for mood disorders (Newton-Howes et al., 2014). As such, it remains unclear 
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whether treatment was not intensive enough for these group of patients. These findings are in 
contrast with many previous studies that did consider this factor by choosing a standard length 
of treatment or controlling for the number of sessions (Dreessen, & Arntz, 1998; Goddard et 
al., 2015; Kampman et al., 2008; Shea et al., 1998). For example, Goddard et al. (2015) still 
found a negative effect of PP after controlling for the number of sessions. Nevertheless, the 
intensity and duration of treatment might be an important confounder to consider in future 
research. A study by Steketee (1990), who treated patients with obsessive-compulsive 
disorder and comorbid personality disorders during an intensive behavioural treatment, 
acknowledges this notion and showed that the effort of the therapist can determine the 
treatment outcome. Steketee (1990) emphasized that the powerful effects of intensive 
treatment may have resulted into no differences between PD and non-PD patients regarding 
treatment outcome. 
4.3 Implications 
This present study has broadened the way on how to examine the prognostic value of PP for 
treatment outcome in mood and anxiety disorders by viewing PP in a dimensional manner. 
Only a few studies have done this before (Schat et al., 2015). The majority of studies merely 
focused on the presence of a comorbid personality disorder. Our study provides evidence that 
there is a group of patients with mood or anxiety disorders who display maladaptive 
personality traits without necessarily meeting diagnostic criteria for a full-blown personality 
disorder (Carlier et al., 2013). The possible influence of dimensional PP rather than 
personality disorders on treatment outcome has increasingly been acknowledged in recent 
years (Reich, Russel, & Vasile, 1993; Reich, 2003). Furthermore, the substantial prognostic 
value of pretest severity for treatment outcome in our study and previous studies demonstrates 
that this an important factor to consider when analysing the independent influence of PP. 
The discussed findings and weaknesses also highlight one clinical implication: 
treatment effectiveness may not be adversely affected by the presence of maladaptive 
personality traits, as we only found small negative effects. Similar to our other findings, some 
studies even found a positive influence of some adverse personality traits, such as cluster A 
traits (i.e. odd, eccentric; Illardi, Craighead, & Evans, 1997). However, it is not yet certain 
what the pure role of PP on treatment outcome is in patients with mood and/or anxiety 
disorders, as pretest severity and variations in the intensity of treatment have been found to 
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greatly influence treatment outcome as well (Steketee, 1990; Kampman et al., 2008).  
4.4 Recommendations 
The discussed limitations and implications lead to two recommendations. We recommend 
taking the potential confounding effects of pretest severity into account when conducting 
further research into the prognostic value of PP for treatment outcome in mood and anxiety 
disorders. The fact that our study and previous studies found much more prognostic value for 
pretest severity than for PP supports this recommendation. Finally, the intensity, duration, and 
type of treatment must also be controlled for in order to purely detect the independent 
influence of PP on treatment outcome, as more intensive or lengthy treatments may obscure 
negative effects of PP on the progress of treatment and its outcome. 
4.5 Conclusion 
This prospective cohort study examined the differential effects of PP on treatment outcome in 
singular and comorbid mood and anxiety disorders among adult outpatients treated at GGZ 
Rivierduinen or Leiden University Medical Centre. The present findings do not confirm 
results from previous studies. A small effect of PP on treatment outcome was found, and 
demonstrated to be similar between the three diagnostic groups.  Several factors such as 
treatment characteristics (i.e. intensity, duration, modality) and pretest severity may account 
for the inconsistent findings between studies regarding the prognostic value of PP. Future 
research is required to purely detect the independent influence of PP on treatment outcome for 
mood and anxiety disorders.  
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Appendix 
Appendix 1 
Frequencies of specific mood and anxiety disorders within the final data sample of N = 5755. 
Clinical data     N   % 
Major depressive disorder, recurrent, moderate 
Posttraumatic stress disorder       
1232 
898   
21,4% 
15,6% 
Generalized anxiety disorder 
Social anxiety disorder 
Panic disorder with agoraphobia 
Specific phobia 
Major depressive disorder, single episode, 
moderate 
Obsessive-compulsive disorder       
898 
675 
651 
625 
556 
 
470   
15,6% 
11,7% 
11,3% 
10,9% 
9,7% 
 
8,2% 
Major depressive disorder, recurrent, 
unspecified 
Dysthymic disorder 
Major depressive disorder, recurrent, severe 
without psychotic features 
Panic disorder without agoraphobia 
Major depressive disorder, recurrent, mild 
Major depressive disorder, single episode, 
unspecified 
Major depressive disorder, single episode, 
severe without psychotic features 
Agoraphobia without history of panic disorder 
Major depressive disorder, single episode, 
mild 
Major depressive disorder, recurrent, in partial 
remission 
Major depressive disorder, single episode, in       
438 
 
427 
381 
 
301 
272 
214 
 
203 
 
191 
179 
 
83 
 
80   
7,6% 
 
7,4% 
6,6% 
 
5,2% 
4,7% 
3,7% 
 
3,5% 
 
3,3% 
3,1% 
 
1,4% 
 
1,4% 
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partial remission 
Major depressive disorder, recurrent, severe 
with psychotic features 
Catatonic disorder due to general medical 
condition 
Major depressive disorder, single episode, 
severe with psychotic features  
Major depressive disorder, recurrent, 
unspecified 
Bipolar II disorder 
Bipolar I disorder, single manic episode, in 
partial remission 
Mood disorder due to general medical 
condition 
Anxiety disorder not otherwise specified 
 
25 
 
17 
 
16 
 
8 
 
6 
4 
 
4 
 
2 
 
0,4% 
 
0,3% 
 
0,3% 
 
0,1% 
 
0,1% 
0,07% 
 
0,07% 
 
0,03% 
 
Appendix 2  
Multiple regression analysis examining the prognostic value of unique subscales of higher-
order DAPP constructs for BSI after max. six months of treatment. 
  
B (SE) Beta t P 95% CI 
Selection variable: depression group 
    Emotional dysregulation:  
F(14, 1657) = 43.95, p < 
0.05; Adj. R
2
 = 0.265 
 
     
  Submissiveness  -0.070(0.022) -0.096 -3.183 0.001** -0.114 to -0.027 
  Cognitive distortion   0.056(0.021)  0.078  2.645 0.008**  0.014-0.097 
  Identity problems 
 
 0.024(0.023)  0.034  1.034 0.298 -0.022 to 0.07 
  Affective lability   0.069(0.026)  0.088  2.678 0.007**  0.019-0.120 
  Oppositionality   0.065(0.021)  0.087  3.164 0.002**  0.025-0.106 
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  Anxiousness  -0.036(0.024) -0.050 -1.484 0.138 -0.083 to 0.012 
  Suspiciousness   0.050(0.020)  0.072  2.482 0.013**  0.01-0.089 
  Social avoidance   0,007(0.021)  0.011  0.333 0.739 -0.034 to 0.047 
  Narcissism  -0.032(0.020) -0.040 -1.598 0.110 -0.071 to 0.007 
  Insecure attachment  -0.017(0.015) -0.029 -1.131 0.258 -0.046 to 0.012 
  Self-harm   0.015(0.016)  0.022  0.916 0.360 -0.017 to 0.046 
Dissocial behaviour: 
F(14, 1664) = 79.31, p < 
0.05; Adj. R
2
 = 0.25  
     
  Stimulus seeking   0.001(0.022)  0.002  0.063 0.950 -0.041 to 0.044 
  Callousness   0.010(0.030)  0.009  0.335 0.738 -0.049 to 0.069 
  Rejection  -0.008(0.020) -0.010 -0.385 0.700 -0.048 to 0.032 
  Conduct problems   0.089(0.031)  0.081  2.884 0.004**  0.028-0.149 
Inhibitedness: 
F(5, 1668) = 110.13 , p < 
0.05; Adj. R
2
 = 0.25  
     
  Intimacy problems   0.067(0.017)  0.089  3.943 0.000**  0.034-0.100 
  Restricted expression  -0.004(0.025)  0.041 -0.214 0.830 -0.039 to 0.031 
Compulsivity 
F(4, 1674) = 136.25, p < 
0.05; Adj. R
2
 = 0.24  
     
  Compulsivity  -0.020(0.016) -0.028 -1.298 0.195 -0.051 to 0.010 
Selection variable: anxiety group 
   Emotional dysregulation: 
F(14, 1986) = 60.43, p < 
0.05; Adj. R
2
 = 0.29 
        Submissiveness  -0.050(0.017) -0.082 -2.894 0.004** -0.083 to -0.016 
  Cognitive distortion   0.050(0.017)  0.077  2.890 0.004**  0.016-0.084 
  Identity problems   0.015(0.019)  0.025  0.773 0.440 -0.023 to 0.052 
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  Affective lability   0.024(0.020)  0.036  1.191 0.234 -0.015 to 0.063 
  Oppositionality   0.045(0.017)  0.067  2.589 0.010**  0.011-0.080 
  Anxiousness   0.024(0.019)  0.040  1.247 0.213 -0.014 to 0.063 
  Suspiciousness   0.052(0.017)  0.080  3.082 0.002**  0.019-0.084 
  Social avoidance   0.018(0.016)  0.034  1.147 0.251 -0.013 to 0.049 
  Narcissism  -0.009(0.016) -0.013 -0.579 0.563 -0.041 to 0.022 
  Insecure attachment   0.004(0.012)  0.007  0.333 0.739 -0.019 to 0.027 
  Self-harm   0.064(0.017)  0.080  3.683 0.000**  0.030 to 0.098 
Dissocial behaviour: 
F(7, 1998) = 105.93, p < 
0.05; Adj. R
2
 = 0.27 
        Stimulus seeking   0.014(0.018)  0.019  0.768 0.442 -0.022 to 0.049 
  Callousness   0.070(0.024)  0.071  2.912 0.004**  0.023-0.118 
  Rejection  -0.027(0.016) -0.038 -1.691 0.091 -0.057 to 0.004 
  Conduct problems   0.087(0.026)  0.080  3.302 0.001**  0.035-0.139 
Inhibitedness: 
F(5, 2002) = 144.77, p < 
0.05; Adj. R
2
 = 0.26 
 
     
  Intimacy problems  0.009(0.014) 0.012 0.596 0.551 -0.020 to 0.037 
  Restricted expression  0.059(0.014) 0.088 4.119 0.000**  0.031-0.087 
Compulsivity 
F(4, 2007) = 173.99, p < 
0.05; Adj. R
2
 = 0.26  
 
    
Compulsivity  0.005(0.012) 0.009 0.441 0.659 -0.018 to 0.029 
Selection variable: comorbid anxiety and depression group 
  Emotional dysregulation:  
F(14, 2027) = 45.22, p < 
0.05; Adj. R
2
 = 0.233 
 
     
  Submissiveness  -0.060(0.025) -0.067 -2.359 0.018** -0.110 to -0.010 
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  Cognitive distortion  -0.007(0.023) -0.008 -0.306 0.760 -0.052 to 0.038 
  Identity problems   0.022(0.028)  0.024  0.769 0.442 -0.034 to 0.077 
  Affective lability   0.068(0.030)  0.066  2.251 0.024**  0.009-0.128 
  Oppositionality  -.001(0.024) -0.001 -0.026 0.979 -0.048 to 0.047 
  Anxiousness  -0.006(0.030) -0.007 -0.205 0.837 -0.064 to 0.052 
  Suspiciousness   0.078(0.021)  0.099  3.671 0.000**  0.036-0.120 
  Social avoidance   0.008(0.023)  0.010  0.359 0.720 -0.037 to 0.054 
  Narcissism  -0.077(0.023) -0.077 -3.385 0.001** -0.121 to -0.032 
  Insecure attachment  -0.006(0.017) -0.007 -0.317 0.751 -0.040 to 0.029 
  Self-harm   0.060(0.018)  0.076  3.423 0.001**  0.026 to 0.095 
Dissocial behaviour: 
F(7, 2041) = 84.81, p < 
0.05; Adj. R
2
 = 0.222 
 
     
  Stimulus seeking   0.027(0.025)  0.027  1.081 0.280 -0.022 to 0.075 
  Callousness  -0.024(0.033) -0.0118 -0.720 0.472 -0.090 to 0.042 
  Rejection  -0.069(0.023) -0.064 -2.731 0.006** -0.109 to -0.018 
  Conduct problems   0.112(0.035)  0.081  3.221 0.001**  0.044 to 0.180 
Inhibitedness: 
F(5, 2046) = 122.65, p < 
0.05; Adj. R
2
 = 0.23 
        Intimacy problems   0.100(0.019)  0.107  5.334 0.000**  0.063-0.137 
  Restricted expression  -0.006(0.021) -0.006 -0.287 0.774 -0.047 to 0.035 
Compulsivity 
F(4, 2056) = 145.70, p 
< 0.05; Adj. R
2
 = 0.22  
     
  Compulsivity  -0.029(0.017) -0.034 -1.669 0.095 -0.062 to 0.005 
Note: DAPP-SF denotes Dimensional Assessment of Personality Psychopathology-Short 
Form; BSI denotes Brief Symptom Inventory; CI denotes confidence interval 
* adjusted for gender and age 
** p < 0.05 
